CAR T-Cell Therapy Results in Secondary Primary Cancers in Approximately 4% of Patients
Shyam A. Patel, MD, PhD, and Saurabh Dahiya, MD, FACP, detail the pathobiology of SPCs after CAR T-cell therapy and findings from a review on the cancers.
Shyam A. Patel, MD, PhD, and Saurabh Dahiya, MD, FACP, detail the pathobiology of SPCs after CAR T-cell therapy and findings from a review on the cancers.
The fight against cancer is complex. It’s global. And it’s indisputably expensive. To access this subscriber-only content please log in or subscribe.If your institution has…
Cisplatin/paclitaxel showed trend towards improved DFS vs cisplatin alone in advanced-stage ovarian cancer.
If colorectal cancer runs in your family, you might wonder whether you will be affected too. Knowing your Lynch syndrome status can provide important clues…
Stop Big Tobacco from targeting Washington kids
Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives…
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
He told a news conference that diversity hiring efforts at the Federal Aviation Administration may have led to safety issues.
Over the last 45 years, prevention and screening interventions have made a greater contribution to averting cancer deaths than have improvements in treatment, according to…
Calling all eye care professionals looking to attend the CRU Eye Symposium this year! Are you curious about which wine matches your personality? Find out…
An abstract is unavailable.